Logo image of LCID

LUCID GROUP INC (LCID) Stock Fundamental Analysis

NASDAQ:LCID - Nasdaq - US5494981039 - Common Stock - Currency: USD

2.42  -0.04 (-1.63%)

After market: 2.42 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LCID. LCID was compared to 38 industry peers in the Automobiles industry. While LCID seems to be doing ok healthwise, there are quite some concerns on its profitability. LCID is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LCID has reported negative net income.
LCID had a negative operating cash flow in the past year.
In the past 5 years LCID always reported negative net income.
In the past 5 years LCID always reported negative operating cash flow.
LCID Yearly Net Income VS EBIT VS OCF VS FCFLCID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1B -2B -3B -4B

1.2 Ratios

LCID has a Return On Assets of -33.72%. This is in the lower half of the industry: LCID underperforms 60.53% of its industry peers.
Looking at the Return On Equity, with a value of -64.10%, LCID is in line with its industry, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
ROA -33.72%
ROE -64.1%
ROIC N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
LCID Yearly ROA, ROE, ROICLCID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LCID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCID Yearly Profit, Operating, Gross MarginsLCID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LCID has more shares outstanding
LCID has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LCID has been reduced compared to a year ago.
LCID Yearly Shares OutstandingLCID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B
LCID Yearly Total Debt VS Total AssetsLCID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -1.56, we must say that LCID is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.56, LCID perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that LCID is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, LCID is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -1.56
ROIC/WACCN/A
WACC7.06%
LCID Yearly LT Debt VS Equity VS FCFLCID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 3.32 indicates that LCID has no problem at all paying its short term obligations.
LCID's Current ratio of 3.32 is amongst the best of the industry. LCID outperforms 92.11% of its industry peers.
LCID has a Quick Ratio of 2.97. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
LCID has a better Quick ratio (2.97) than 94.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 2.97
LCID Yearly Current Assets VS Current LiabilitesLCID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.56% over the past year.
Looking at the last year, LCID shows a very strong growth in Revenue. The Revenue has grown by 40.67%.
The Revenue has been growing by 181.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)40.67%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%36.07%

3.2 Future

The Earnings Per Share is expected to grow by 13.44% on average over the next years. This is quite good.
LCID is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 70.64% yearly.
EPS Next Y20.75%
EPS Next 2Y21.61%
EPS Next 3Y19.54%
EPS Next 5Y13.44%
Revenue Next Year72.98%
Revenue Next 2Y86%
Revenue Next 3Y88.58%
Revenue Next 5Y70.64%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LCID Yearly Revenue VS EstimatesLCID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
LCID Yearly EPS VS EstimatesLCID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LCID. In the last year negative earnings were reported.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCID Price Earnings VS Forward Price EarningsLCID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCID Per share dataLCID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

LCID's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.61%
EPS Next 3Y19.54%

More info and screens

0

5. Dividend

5.1 Amount

LCID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCID GROUP INC

NASDAQ:LCID (8/1/2025, 8:00:02 PM)

After market: 2.42 0 (0%)

2.42

-0.04 (-1.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners73.72%
Inst Owner Change0.06%
Ins Owners0.26%
Ins Owner Change14.79%
Market Cap7.44B
Analysts52.38
Price Target2.57 (6.2%)
Short Float %13.09%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.65%
Min EPS beat(2)14.21%
Max EPS beat(2)15.08%
EPS beat(4)3
Avg EPS beat(4)7.84%
Min EPS beat(4)-7.42%
Max EPS beat(4)15.08%
EPS beat(8)5
Avg EPS beat(8)0.39%
EPS beat(12)8
Avg EPS beat(12)3.33%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.05%
Min Revenue beat(2)-7.41%
Max Revenue beat(2)7.31%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)7.31%
Revenue beat(8)3
Avg Revenue beat(8)-5.89%
Revenue beat(12)3
Avg Revenue beat(12)-11.38%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.18%
PT rev (3m)-0.18%
EPS NQ rev (1m)-0.6%
EPS NQ rev (3m)12.51%
EPS NY rev (1m)0%
EPS NY rev (3m)5.01%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)-11.67%
Revenue NY rev (1m)-2.52%
Revenue NY rev (3m)-6.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.55
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 1.53
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.28
BVpS1.58
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.72%
ROE -64.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 261.02%
Cap/Sales 97.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 2.97
Altman-Z -1.56
F-Score4
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)421.76%
Cap/Depr(5y)1286.62%
Cap/Sales(3y)146.37%
Cap/Sales(5y)2710.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y20.75%
EPS Next 2Y21.61%
EPS Next 3Y19.54%
EPS Next 5Y13.44%
Revenue 1Y (TTM)40.67%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%36.07%
Revenue Next Year72.98%
Revenue Next 2Y86%
Revenue Next 3Y88.58%
Revenue Next 5Y70.64%
EBIT growth 1Y3.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.55%
EBIT Next 3Y16.76%
EBIT Next 5Y17.04%
FCF growth 1Y24.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.74%
OCF growth 3YN/A
OCF growth 5YN/A